Kansas City's defense finished Super Bowl LV with eleven penalties for 120 yards.
Kansas City's defense finished Super Bowl LV with eleven penalties for 120 yards.
Pipedrive, the leading CRM for sales and marketing teams, announced today it was named a Category Leader for Lead Generation software by GetApp, a Gartner company. Category Leaders are designed to help small businesses evaluate which software products may be right for them.
Kohl's Corp topped estimates for holiday-quarter net sales on Tuesday, as people staying at home due to the COVID-19 pandemic bought more from the department store chain's online store. Shares of the mid-priced chain rose 2% as it reinstated a quarterly dividend and said it would buy back shares worth $200 million to $300 million. Department stores, including Kohl's, have been doubling down on cookware, kitchen electrics, beauty products, athleisure apparel and activewear, as they look to beat lower demand for dresses and formal clothing from consumers working from home.
Stock futures edged lower Tuesday morning as the major indexes retreated slightly after rallying a day earlier.
VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) -- Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) ("Lithium Americas" or the "Company") has reported financial and operating results for the fourth quarter and year ended December 31, 2020. This news release should be read in conjunction with Lithium Americas’ consolidated financial statements and management's discussion and analysis for the year ended December 31, 2020, which are available on the Company’s website and SEDAR. All amounts are in U.S. dollars unless otherwise indicated. Highlights Caucharí-Olaroz Lithium Project (“Caucharí-Olaroz”): Construction activities at Caucharí-Olaroz continue to advance with enhanced COVID-19 health and safety protocols in place.Capital expenditures for the Project remain on budget with $477 million (84%) of the $565 million committed, including $388 million (69%) spent, as of December 31, 2020.Capital costs attributable to COVID-19 during the construction period, including costs for quarantine and extra camp capacity, are being assessed and now reported separate from the budgeted capital expenditures.Significant progress has been made on the lime plant, solvent extraction plant and lithium carbonate plant.The solar evaporation ponds are well advanced with sufficient brine inventory to support production ramp up.The health and safety of the workforce and surrounding communities remains the highest priority with no positive cases of COVID-19 reported at site in over 130 days.Based on the latest construction schedule, which assumes a reduced workforce at site in accordance with COVID-19 protocols throughout construction, the Company expects first production in mid-2022.In Q1 2021, Marcelo Cabral was appointed General Manager responsible for the development and commissioning of Caucharí-Olaroz. Mr. Cabral was previously with Gold Fields Ltd. and responsible for commissioning MMG Ltd.’s Las Bambas copper project in Peru.In H1 2021, the Jujuy Energia y Mineria Sociedad del Estado (“JEMSE”), a company owned by the Government of Jujuy province, is expected to complete the exercise of its 2012 participation right, at which point it will receive and hold an 8.5% interest in Caucharí-Olaroz. Thacker Pass Lithium Project (“Thacker Pass”): On January 15, 2021, the US Bureau of Land Management issued the Record of Decision following completion of the National Environmental Policy Act process.All remaining state permits and water right transfers required to commence construction are expected later this year.The process testing facility in Reno, Nevada, continues to operate with enhanced COVID-19 protocols in place and has produced over 15,000 kg of lithium sulphate solution.The Company continues to evaluate partnership and financing opportunities for Thacker Pass, including the possibility of a joint venture partner.The Company contemplates that the feasibility study will include an initial production capacity greater than 20,000 tonnes per annum of lithium carbonate equivalent previously considered. Based on ongoing discussions with potential partners and customers, the Company expects that a finalized development plan and timeline of the related feasibility study will be determined as the prospective commercial arrangements are advanced. Corporate: As at December 31, 2020, the Company had $148 million in cash and cash equivalents ($518 million as at February 28, 2021).On January 22, 2021, the Company closed an underwritten public offering of shares of its common stock and issued 18,181,818 common shares at a price of $22.00 per Common Share for gross proceeds to the Company of approximately $400 million (approximately $377 million net proceeds).On November 30, 2020, Lithium Americas completed an at-the-market equity program (“ATM Program”) and issued a total of 9,266,587 common shares from treasury for gross proceeds of approximately $100 million ($97 million net proceeds).As at December 31, 2020, the Company had $184 million in undrawn credit with $96 million drawn from the $205 million senior credit facility and $25 million from its $100 million unsecured, limited recourse, subordinated loan facility.In February 2021, Ignacio Celorrio was promoted to President, Latin America to act as the Company’s representative in Latin America and oversee the management of the Caucharí-Olaroz project.In November 2020, Lithium Americas published its inaugural 2019 Sustainability Report prepared with reference to the Global Reporting Initiative Standards, which includes reporting on the United Nations’ Sustainable Development Goals. Financial Results Selected consolidated financial information is presented as follows: (in US$ million except per share information)Year endedDecember 31, 2020 Year endedDecember 31, 2019 $ $Expenses (30.6) (15.7)Net (loss)/income (36.2) 51.7(Loss)/income per share - basic (0.39) 0.58 (in US$ million)As atDecember 31, 2020 As atDecember 31, 2019 $ $Cash and cash equivalents 148.1 83.6Total assets 326.7 293.8Total long-term liabilities (127.3) (119.2) During the year ended December 31, 2020, total assets increased primarily due to the proceeds raised from the $100.0 million ATM Program, partially offset by a decrease as a result of closing the transaction with a subsidiary of Ganfeng Lithium Co. Ltd. (“Ganfeng”) and cessation of proportional consolidation of Caucharí-Olaroz with transition to equity accounting for the project investment. Cash increased due to the ATM Program proceeds and the $40.0 million of loans repaid to the Company upon closing of the transaction with Ganfeng partially offset by capital expenditures on Caucharí-Olaroz and operating activities, including exploration expenditures on Thacker Pass. Total long-term liabilities increased primarily as a result of a $24.7 million drawdown on the Company’s limited recourse loan facility and a $12.0 million drawdown on the Company’s senior credit facility, partially offset by the effect of closing the transaction with Ganfeng. Net loss for the year ended December 31, 2020, was $36.2 million compared to net income of $51.7 million for the year ended December 31, 2019. Net income in 2019 was a result of the gain on dilution of interest in Caucharí-Olaroz. Qualified Person: The scientific and technical information in this news release has been reviewed and approved by Dr. Rene LeBlanc, a Qualified Person for purposes of NI 43-101 by virtue of his experience, education and professional association. Dr. LeBlanc is the Chief Technical Officer of the Company. Information on the Company’s data verification and QA / QC procedures is contained in Lithium Americas’ current technical reports for Caucharí-Olaroz and Thacker Pass, available at www.sedar.com. About Lithium Americas: Lithium Americas is a development-stage company with projects in Jujuy, Argentina and Nevada, United States. The Company trades on both the Toronto Stock Exchange and on the New York Stock Exchange, under the ticker symbol “LAC”. For further information contact:Lithium Americas Corp.Investor RelationsSuite 300 – 900 West Hastings StreetVancouver, BC, V6C 1E5Telephone: 778-656-5820Email: email@example.comWebsite: www.lithiumamericas.com Forward-Looking Statements: This news release contains “forward-looking information” and “forward-looking statements” (which we refer to collectively as forward-looking information) under the provisions of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking information. Examples of forward-looking information in this news release include, among other things, statements related to: successful development of the Caucharí-Olaroz project and the Thacker Pass project, including timing, progress, construction, milestones, anticipated production and results thereof; the expected outcome of any complaints or claims made or that could be made concerning the environmental permitting process in the United States for the Thacker Pass project; the expected benefits from previous transactions; expectations and anticipated impact of the COVID-19; capital expenditures and programs; estimates of the mineral resources and mineral reserves at the Company’s properties; development of mineral resources and mineral reserves; government regulation of mining operations and treatment under governmental and taxation regimes; the future price of commodities, including lithium; the realization of mineral resources and mineral reserves estimates, including whether mineral resources will ever be developed into mineral reserves and information and underlying assumptions related thereto; the timing and amount of future production; currency exchange and interest rates; expected outcome and timing of environmental surveys and permit applications and other environmental matters; the Company’s ability to raise capital; expected expenditures to be made by the Company on its properties; the timing, cost, quantity, capacity and product quality of production of the Caucharí-Olaroz project, which is held and operated through an entity in Argentina 49% owned by the Company and 51% owned by Ganfeng; successful operation of the Caucharí-Olaroz project under its co-ownership structure; the expected timing for JEMSE to exercise its right to acquire an interest in the Caucharí-Olaroz project; whether the Company will ever be able to realize on an additional debt funding commitment, including the terms and timing thereof; ability to produce high purity battery grade lithium products; the timing, cost, quantity, capacity and product quality of production at the Thacker Pass project; results of the Company’s engineering, design and permitting program at the Thacker Pass project, including that the Company meets deadlines and receives permits as anticipated; successful results from the Company’s testing facility and third-party tests related thereto; capital costs, operating costs, and sustaining capital requirements of the Caucharí-Olaroz project and the Thacker Pass project; timing, results and completion of a feasibility study for the Thacker Pass project; the Company’s share of the expected capital expenditures for the construction of the Caucharí-Olaroz project and for permitting and Thacker Pass project feasibility study activities at the Thacker Pass project; ability to achieve capital cost efficiencies; stability and inflation related to the Argentine peso, whether the Argentine government implements additional foreign exchange and capital controls, and the effect of current or any additional regulations on the Company’s operations; approval of pending patents; and the potential for partnership and financing scenarios for the Thacker Pass project. Forward-looking information is based upon a number of factors and assumptions that, if untrue, could cause the actual results, performances or achievements of the Company to be materially different from future results, performances or achievements expressed or implied by such information. Such information reflects the Company’s current views with respect to future events and is necessarily based upon a number of assumptions that, while considered reasonable by the Company today, are inherently subject to significant uncertainties and contingencies. These assumptions include, among others, the following: current technological trends; a cordial business relationship between the Company and Ganfeng for the Caucharí-Olaroz project; ability of the Company to fund, advance and develop the Caucharí-Olaroz project and the Thacker Pass project, and the respective impacts of the projects when production commences; the Company’s ability to operate in a safe and effective manner; uncertainties relating to receiving and maintaining mining, exploration, environmental and other permits or approvals in Nevada and Argentina; demand for lithium, including that such demand is supported by growth in the electric vehicle market; the impact of increasing competition in the lithium business, and LAC’s competitive position in the industry; general economic conditions; the stable and supportive legislative, regulatory and community environment in the jurisdictions where the Company operates; stability and inflation of the Argentinian peso, including any foreign exchange or capital controls which may be enacted in respect thereof, and the effect of current or any additional regulations on the Company’s operations; the impact of unknown financial contingencies, including litigation costs, on the Company’s operations; gains or losses, in each case, if any, from short-term investments in Argentine bonds and equities; estimates of and unpredictable changes to the market prices for lithium products; exploration, development and construction costs for the Caucharí-Olaroz project and the Thacker Pass project; estimates of mineral resources and mineral reserves, including whether mineral resources will ever be developed into mineral reserves; reliability of technical data; anticipated timing and results of exploration, development and construction activities, including the impact of COVID-19 on such timing; timely responses from governmental agencies responsible for reviewing and considering the Company’s permitting activities at the Thacker Pass project; the Company’s ability to obtain additional financing, including pursuant to an additional debt funding commitment, on satisfactory terms or at all; the ability to develop and achieve production at any of the Company’s mineral exploration and development properties; the impact of COVID-19 on the Company’s business; the expected benefits from prior transactions; accuracy of development budget and construction estimates; and preparation of a development plan and feasibility study for lithium production at the Thacker Pass project. Forward-looking information also involve known and unknown risks that may cause actual results to differ materially, these risks include, among others, inherent risks in the development of capital intensive mineral projects (including as co-owners), variations in mineral resources and mineral reserves, global demand for lithium, recovery rates and lithium pricing, risks associated with successfully securing adequate financing, changes in project parameters and funding thereof, risks related to growth of lithium markets and pricing for products thereof, changes in legislation, governmental or community policy, political risk associated with foreign operations, permitting risk, including receipt of new permits and maintenance of existing permits, title and access risk, cost overruns, unpredictable weather and maintenance of natural resources, unanticipated delays, intellectual property risks, currency and interest rate fluctuations, operational risks, health and safety risks, and general market and industry conditions. Additional risks, assumptions and other factors are set out in the Company’s management discussion analysis and most recent annual information form, copies of which are available on SEDAR at www.sedar.com. Although the Company has attempted to identify important risks and assumptions, given the inherent uncertainties in such forward-looking information, there may be other factors that cause results to differ materially. Forward-looking information is made as of the date hereof and the Company does not intend, and expressly disclaims any obligation to, update or revise the forward-looking information contained in this news release, except as required by law. Accordingly, readers are cautioned not to place undue reliance on forward-looking information.
Global Pre-engineered Buildings Market 2021-2025 The analyst has been monitoring the pre-engineered buildings market and it is poised to grow by USD 5. 79 bn during 2021-2025, progressing at a CAGR of 7% during the forecast period.New York, March 02, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Pre-engineered Buildings Market 2021-2025" - https://www.reportlinker.com/p05976106/?utm_source=GNW Our report on pre-engineered buildings market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the advantages of PEBs over traditional buildings and an increase in demand for airports. In addition, the advantages of PEBs over traditional buildings is anticipated to boost the growth of the market as well.The pre-engineered buildings market analysis includes end-user segment and geographical landscapes.The pre-engineered buildings market is segmented as below:By End-user• Industrial• Commercial• Infrastructure• ResidentialBy Geographical Landscapes• APAC• North America• Europe• MEA• South AmericaThis study identifies the increasing demand for warehouses as one of the prime reasons driving the pre-engineered buildings market growth during the next few years.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on pre-engineered buildings market covers the following areas:• Pre-engineered buildings market sizing• Pre-engineered buildings market forecast• Pre-engineered buildings market industry analysisThis robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pre-engineered buildings market vendors that include ATCO Ltd., Cornerstone Building Brands Inc., Everest Industries Ltd., Interarch Building Products Pvt. Ltd., Lindab AB, Nucor Corp., PEB Steel Buildings Co. Ltd., Pennar Industries Ltd., Tata BlueScope Steel Pvt. Ltd., and Zamil Industrial Investment Co. Also, the pre-engineered buildings market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.Read the full report: https://www.reportlinker.com/p05976106/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Murphy Oil Corporation (the "Company") (NYSE:MUR) announced today that, subject to market conditions, it intends to offer $550 million of Senior Notes due 2028 pursuant to an effective shelf registration statement previously filed with the Securities and Exchange Commission ("SEC").
Two investment firms will buy a majority stake in Hertz Global Holdings Inc for $4.2 billion under a restructuring plan expected to help it out of bankruptcy by early- to mid-summer, the car rental company said in a filing on Tuesday. Under the proposed investment, Knighthead Capital Management LLC and Certares Opportunities LLC will buy up to 100% of Hertz's shares, with the funds expected to finance its U.S. vehicle fleet and slash corporate debt. Hertz filed for bankruptcy protection in May after its business was decimated by the COVID-19 pandemic and talks with creditors failed to result in much-needed relief.
Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Natural Language Processing Market by Component, Type (Statistical, Hybrid), Application (Automatic Summarization, Sentiment Analysis, Risk & Threat Detection), Deployment Mode, Organization Size, Vertical, and Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The Global Natural Language Processing (NLP) Market Size to Grow from USD 11.6 Billion in 2020 to USD 35.1 Billion by 2026, at a Compound Annual Growth Rate (CAGR) of 20.3% during the Forecast Period. Growing demand for cloud-based NLP solutions to reduce overall costs and better scalability and increasing usage of smart devices to facilitate smart environments are expected to drive the NLP market growth. The rise in the adoption of NLP-based applications across verticals to enhance customer experience and increase in investments in the healthcare vertical is expected to offer opportunities for NLP vendors.The global spread of COVID-19 has generated numerous privacy, data protection, security, and compliance questions. These challenges have increased the need for companies and organizations to secure and analyze their sensitive data for strategic business decisions. New practices such as work from home and social distancing have increased the requirement of NLP solutions and services, and the development of digital infrastructures for large-scale technology deployments. Organizations are implementing NLP solutions and services to access the landscape of scientific papers relevant to the coronavirus pandemic. Moreover, scientists are developing COVID-19 therapeutics which uses NLP technology to track new papers, particularly around drug or vaccine safety. The services segment is expected to grow at a higher CAGR during the forecast period The NLP market is segmented on the basis of components into solutions and services. The services segment is expected to grow at a higher CAGR during the forecast period. NLP services play a vital role in the functionality of NLP platform and software tools. These services are an integral step in deploying tools and are taken care of by solution, platform, and service providers. The demand for NLP software tools and platform is increasing globally due to the rising demand to gain real-time insights from voice or speech data across BFSI, healthcare and life sciences, and retail and eCommerce vertical. On-premises segment is expected to grow at a higher CAGR during the forecast period The NLP market by deployment mode has been segmented into on-premises and cloud. Enterprises opt for the deployment mode based on their requirements regarding the scalability and level of data security required. The on-premises mode is the most preferable among the enterprises, which consider data as a valuable asset and need to maintain high-level security to comply with regulations. The cloud deployment mode is dominating the market due to its advantages, such as scalability, easy availability, and cost-savings. The cloud segment is expected to account for a larger market size during the forecast period. Among verticals, the healthcare and life sciences segment to grow at the highest CAGR during the forecast period The NLP market is segmented into the various verticals, particularly BFSI, IT and telecom, retail and eCommerce, healthcare and life sciences, transportation and logistics, government and public sector, energy and utilities, manufacturing, others (education, travel and hospitality, and media and entertainment). The healthcare and life sciences vertical is expected to grow at the highest CAGR during the forecast period. The vertical's high growth rate can be attributed to the increasing healthcare complexities and growing need for advanced NLP-driven EHRs to extract meaningful insights from unstructured clinical data. To address the COVID-19 impact on the BFSI vertical, the adoption of digital technologies such as video banking facilities, AI-supported tools, and conversational platforms has become essential. North America to hold the largest market size during the forecast period The NLP market has been segmented into five regions: North America, Europe, APAC, MEA, and Latin America. Among these regions, North America is projected to hold the largest market size during the forecast period. Improvements in cloud computing platforms, which are now more efficient, affordable, and capable of processing complex information, have led to the growth of inexpensive software development tools and plentiful datasets, which play a vital role in the development of AI technology in the US market. APAC is expected to grow at the highest CAGR during the forecast period on account of the rising awareness and increasing AI investments. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Attractive Opportunities in Natural Language Processing Market4.2 Market: Top Three Applications4.3 Market: by Component and Top Three Verticals4.4 Market, by Region 5 Market Overview5.1 Introduction5.2 Natural Language Processing: Evolution5.3 Natural Language Processing: Architecture5.4 Market Dynamics5.4.1 Drivers22.214.171.124 Increasing Usage of Smart Devices to Facilitate Smart Environments126.96.36.199 Growing Demand for Cloud-Based NLP Solutions to Reduce Overall Costs and Better Scalability188.8.131.52 Rising Urge of Predictive Analytics to Reduce Risks and Identify Growth Opportunities5.4.2 Restraints184.108.40.206 Complexities due to the Usage of Code-Mixed Language while Implementing NLP Solutions220.127.116.11 Limitations in the Development of NLP Technology Using Neural Networks Restricting the Usage of Cloud-Based Services5.4.3 Opportunities18.104.22.168 Increase in Investments in the Healthcare Vertical22.214.171.124 Rise in the Adoption of NLP-Based Applications Across Verticals to Enhance Customer Experience5.4.4 Challenges126.96.36.199 Regulatory and Privacy Concerns Over Data Security188.8.131.52 Interoperability and Reliability Issues while Deploying NLP Algorithms5.4.5 Cumulative Growth Analysis5.5 Case Study Analysis5.5.1 Introduction184.108.40.206 Use Case: Scenario 220.127.116.11 Use Case: Scenario 18.104.22.168 Use Case: Scenario 22.214.171.124 Use Case: Scenario 126.96.36.199 Use Case: Scenario 188.8.131.52 Use Case: Scenario 65.6 Natural Language Processing Market: COVID-19 Impact5.7 Patent Analysis5.8 Supply Chain Analysis5.9 Value Chain Analysis5.10 Regulatory Landscape5.10.1 General Data Protection Regulation5.10.2 Health Insurance Portability and Accountability Act of 19965.10.3 Governance, Risk, and Compliance5.10.4 European Union Data Protection Regulation5.10.5 Can-Spam Act5.10.6 Sarbanes-Oxley Act of 20025.11 Pricing Model Analysis5.12 Porter's Five Forces Analysis5.12.1 Threat of New Entrants5.12.2 Threat of Substitutes5.12.3 Bargaining Power of Suppliers5.12.4 Bargaining Power of Buyers5.12.5 Intensity of Competitive Rivalry5.13 Technology Analysis5.13.1 Artificial Intelligence and Natural Language Processing5.13.2 Deep Learning and Natural Language Processing5.13.3 Big Data and Natural Language Processing 6 Natural Language Processing Market, by Component6.1 Introduction6.1.1 Components: COVID-19 Impact6.1.2 Components: Market Drivers6.2 Solutions6.2.1 Platform6.2.2 Software Tools6.3 Services6.3.1 Professional Services184.108.40.206 Consulting220.127.116.11 System Integration and Implementation18.104.22.168 Support and Maintenance6.3.2 Managed Services 7 Natural Language Processing Market, by Deployment Mode7.1 Introduction7.1.1 Deployment Modes: COVID-19 Impact7.1.2 Deployment Modes: Market Drivers7.2 On-Premises7.3 Cloud 8 Natural Language Processing Market, by Organization Size8.1 Introduction8.1.1 Organization Size: COVID-19 Impact8.1.2 Organization Size: Market Drivers8.2 Small and Medium-Sized Enterprises8.3 Large Enterprises 9 Natural Language Processing Market, by Type9.1 Introduction9.1.1 Types: COVID-19 Impact9.1.2 Types: Market Drivers9.2 Rule-Based9.3 Statistical9.4 Hybrid 10 Natural Language Processing Market, by Application10.1 Introduction10.1.1 Applications: COVID-19 Impact10.1.2 Applications: Market Drivers10.2 Sentiment Analysis10.3 Data Extraction10.4 Risk and Threat Detection10.5 Automatic Summarization10.6 Content Management10.7 Language Scoring10.8 Others 11 Natural Language Processing Market, by Vertical11.1 Introduction11.1.1 Verticals: COVID-19 Impact11.1.2 Verticals: Market Drivers11.2 Banking, Financial Services, and Insurance11.3 It and Telecom11.4 Retail and Ecommerce11.5 Healthcare and Life Sciences11.6 Transportation and Logistics11.7 Government and Public Sector11.8 Energy and Utilities11.9 Manufacturing11.10 Others 12 Natural Language Processing Market, by Region12.1 Introduction12.2 North America12.3 Europe12.4 Asia-Pacific12.5 Middle East and Africa12.6 Latin America 13 Competitive Landscape13.1 Overview13.2 Market Evaluation Framework13.3 Market Share, 202013.4 Historic Revenue Analysis of Key Market Players13.5 Key Market Developments13.5.1 New Product Launches and Product Enhancements13.5.2 Business Expansions13.5.3 Mergers and Acquisitions13.5.4 Partnerships, Agreements, Contracts, and Collaborations13.6 Company Evaluation Matrix Definitions and Methodology13.7 Company Evaluation Matrix, 202013.7.1 Star13.7.2 Emerging Leaders13.7.3 Pervasive13.7.4 Participants13.7.5 Strength of Product Portfolio13.7.6 Business Strategy Excellence13.8 Startup/SME Evaluation Matrix, 202013.8.1 Progressive Companies13.8.2 Responsive Companies13.8.3 Dynamic Companies13.8.4 Starting Blocks13.8.5 Strength of Product Portfolio13.8.6 Business Strategy Excellence 14 Company Profiles14.1 Introduction14.2 IBM14.3 Microsoft14.4 Google14.5 Amazon Web Services14.6 Facebook14.7 Apple14.8 3M14.9 Intel14.10 Baidu14.11 SAS Institute14.12 Linguamatics14.13 Inbenta14.14 Health Fidelity14.15 Veritone14.16 Dolbey14.17 Narrative Science14.18 Bitext14.19 Conversica14.20 Sparkcognition14.21 Automated Insights14.22 Gnani.Ai14.23 Niki.Ai14.24 Mihup14.25 Observe.Ai14.26 Hyro14.27 Just Ai14.28 Ragavera 15 Adjacent and Related Markets15.1 Introduction15.2 NLP in Healthcare and Life Sciences Market - Global Forecast to 202515.2.1 Market Definition15.2.2 Market Overview22.214.171.124 NLP in Healthcare and Life Sciences Market Size, by Component126.96.36.199 NLP in Healthcare and Life Sciences Market Size, by Type188.8.131.52 NLP in Healthcare and Life Sciences Market Size, by Deployment Mode184.108.40.206 NLP in Healthcare and Life Sciences Market Size, by Organization Size220.127.116.11 NLP in Healthcare and Life Sciences Market Size, by Application18.104.22.168 NLP in Healthcare and Life Sciences Market Size, by End-user22.214.171.124 NLP in Healthcare and Life Sciences Market Size, by Region15.3 Conversational AI Market- Global Forecast to 202515.3.1 Market Definition15.3.2 Market Overview126.96.36.199 Conversational AI Market, by Component188.8.131.52 Conversational AI Market, by Type184.108.40.206 Conversational AI Market, by Technology220.127.116.11 Conversational AI Market, by Deployment Mode18.104.22.168 Conversational AI Market, by Application22.214.171.124 Conversational AI Market, by Vertical126.96.36.199 Conversational AI Market, by Region 16 Appendix16.1 Industry Experts16.2 Discussion Guide16.3 Knowledge Store: The Subscription Portal16.4 Available Customizations For more information about this report visit https://www.researchandmarkets.com/r/ac4vu1 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The company has already secured several needle-moving investments this year, with more in the pipeline.
Chelsea and Manchester United will go head-to-head for Erling Braut Haaland this summer. The race for the 20-year-old is only intensified by a buyout clause in his Borussia Dortmund contract set at around £65million and reportedly active in 2022. The insistence on a release clause terrified United during negotiations with his agent Mino Raiola in 2019, with Old Trafford’s hierarchy concerned they would have no control over the player Ole Gunnar Solskjaer nurtured at Molde and believed could spearhead a daunting attack along with Marcus Rashford, Mason Greenwood and another target in Jadon Sancho.
Abu Dhabi state fund Mubadala has hired banks to arrange a planned dual-tranche issue of euro-denominated bonds, a document seen by Reuters showed. Citi and JPMorgan were hired as global coordinators, with Abu Dhabi Commercial Bank, BNP Paribas, First Abu Dhabi Bank, ING, Morgan Stanley and Standard Chartered as joint bookrunners, the document from one of the banks showed. Reuters reported last month that Mubadala was planning an international bond sale.
Herbarium LA, the only vertically licensed cannabis dispensary in Los Angeles, opens a retail store focused on wellness and medical needs in Lompoc.
Global Hepatocellular Carcinoma Drugs Market 2021-2025 The analyst has been monitoring the hepatocellular carcinoma drugs market and it is poised to grow by $ 106. 48 million during 2021-2025, progressing at a 4.New York, March 02, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Hepatocellular Carcinoma Treatment Market 2021-2025" - https://www.reportlinker.com/p06028668/?utm_source=GNW 10% during the forecast period. Our report on hepatocellular carcinoma drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of liver diseases and lifestyle diseases and growing prevalence of lifestyle diseases. In addition, growing prevalence of lifestyle diseases is anticipated to boost the growth of the market as well.The hepatocellular carcinoma drugs market analysis includes the therapy segment and geographic landscape.The hepatocellular carcinoma drugs market is segmented as below:By Therapy• Chemotherapy• Brachytherapy• Ablation therapyBy Geographical Landscapes• North America• Europe• APAC• ROWThis study identifies the increasing product launches as one of the prime reasons driving the hepatocellular carcinoma drug market growth during the next few years.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on hepatocellular carcinoma drugs market covers the following areas:• Hepatocellular carcinoma drugs market sizing• Hepatocellular carcinoma drugs market forecast• Hepatocellular carcinoma drugs market industry analysisThis robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatocellular carcinoma drugs market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Johnson & Johnson, and Pfizer Inc. Also, the hepatocellular carcinoma drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.Read the full report: https://www.reportlinker.com/p06028668/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
India is ready to offer incentives to ensure Tesla Inc's cost of production would be less than in China if the carmaker commits to making its electric vehicles in the south Asian country, transport minister Nitin Gadkari told Reuters. Gadkari's pitch comes weeks after billionaire Elon Musk's Tesla registered a company in India in a step towards entering the country, possibly as soon as mid-2021.
Skeljungur hf.'s Annual General Meeting will be held on Thursday, March 4, 2021 at 16:00 at Icelandair Hotel Reykjavík Natura, in meeting rooms no. 2 and 3., Nauthólsvegur 52, 102 Reykjavík. The deadline for declaring candidacy for the Board of Directors and the Nomination Committee of Skeljungur has passed. The following are the candidates for the Board of Directors of Skeljungur: Birna Ósk EinarsdóttirDagný HalldórsdóttirJón Ásgeir JóhannessonNanna Björk ÁsgrímsdóttirSigurður Kristinn EgilssonÞórarinn Arnar Sævarsson For further information on each candidate, please find a short bio attached and in the Nomination Committee’s report on Skeljungur’s website: https://en.skeljungur.is/shareholder-meeting-2021 According to the Articles of Association of the Company the Board of Directors shall be comprised of five members and the ratio of each gender within the Board shall be no less than 40%. The Board of the Company received a rightful claim for a multiplication election from shareholders that control more than 1/10 of the share capital, cf. Article 63 (7) of Act No. 2/1995 on Public Limited Companies. A multiplication election will therefore be applied for the election of members of the Board of Directors at the meeting. A multiplication election is carried out as follows: There shall be an election between individuals. The weight of each vote shall be multiplied by the number of Directors to be elected and each shareholder may divide his voting power, thus computed, in any proportion he chooses himself on to as many persons as are to be elected or fewer. In case a ballot ticket does not indicate the division of votes between those for whom these are cast, they shall be divided equally. The following are candidates for the Nomination Committee: Katrín S. ÓladóttirSigurður Kári Árnason According to the code of conduct for Skeljungur’s Nomination Committee two committee members shall be elected by the shareholders’ meeting and the new Board shall elect one of their own following the shareholders’ meeting. Consequently, Katrín and Sigurður, will be elected to the Board without a ballot at the meeting. Further information on the candidates is attached. All documents for the AGM can be found on the company’s website: https://en.skeljungur.is/shareholder-meeting-2021 Shareholders are encouraged to register in advance to the AGM in light of Covid-19 restrictions by sending their name and id.no. and if appropriate a filled-out mandate to email@example.com. Shareholders can also register for the meeting at the meeting location, from 15:00, on the meeting date. For further information please contact Árni Pétur Jónsson, CEO, firstname.lastname@example.org. www.skeljungur.ishttps://www.linkedin.com/company/skeljungur-hf/ Attachment Candidates to the Board of Directors and Nomination Committee of Skeljungur - AGM March 4, 2021
Target Corp on Tuesday reported a 21% jump in holiday quarter revenue, much higher than analysts' estimates, as same-day delivery and store pick-up services helped fulfill robust demand for home goods, toys and groceries during the pandemic. Over the past year, Target and Walmart Inc consistently performed better than Wall Street expected as the deep-pocketed national retail chains amped up their online businesses during the health crisis and swiped market share from smaller rivals who rely more on their physical stores. Still, Target held back on providing sales and earnings forecast for fiscal 2021, citing continued uncertainty over consumer shopping patterns amid the health crisis.
On the back of goals to Matt Simon and Marco Urena the Central Coast Mariners have cemented their spot of top of the league ladder with a 2 - 1 win over the Perth Glory.
Dublin, March 02, 2021 (GLOBE NEWSWIRE) -- The "Oncology Information System Market by Software (Patient Information System, TPS, RIS, PACS, Services), Application (Medical, Radiation, Surgical Oncology), Enduser (Hospitals, Cancer Care Centers, Government Institution, Academia) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering. The Oncology Information Systems Market is Projected to Reach USD 9.5 Billion by 2025 from USD 6.7 Billion in 2020, at a CAGR of 7.4% Growth of the market is mainly attributed to the technological advancements; increasing incidences of cancer cases, and growing public and private investments, funding, and grants are driving the global oncology information systems market. However, complex regulatory frameworks that delay the approval of new oncology information systems is expected to challenge market growth to a certain extent. In terms of products, Software segment to register significant growth during the forecast period. Based on the product, the oncology information systems market is segmented into software, and professional services. Software products include patient information systems, treatment planning systems, and treatment management systems & medical image analysis systems. Significant growth of the orthopedic implants and devices segment is attributed to the ongoing product approval of oncology informatio solutions , increasing agreement between OIS vendors and multinational hospitals for the impementation of oncology information systems , and the increasing availability of these products in major markets. These software allow early recovery of the cancer patients and planned procedure which have led to the growth of this segment. In terms application, radiation oncology segment to register significant growth during the forecast period. Based on the application, the oncology information systems market is segmented into radiation oncology, medical oncology and surgical oncology. The radiation oncology segment accounted for a larger share of in the market in 2019. The increasing prevalence recurrence of secondary cancer cases , growing number of radiosurgery procedures and increasing customer base for oncology information systems for radiology are factors expected to drive the growth of this market segment in the coming years. Hospitals & Diagnostic Imaging Centers segment is expected to account for the largest share of the oncology information systems market. On the basis of end-users, the oncology information systems market has been segmented into hospitals & diagnostic imaging centers, ablation & cancer care centers, government institutions, and research facilities. The growth of this segment is attributed to the significant number of availability of state-of-the-art facilities for diagnosis, treatment, and disease management, as well as trained personnel, has ensured a steady demand for hospital-based care and the growing number of hospitals across major markets. The inflow of cancer patients is considerably higher in hospitals as compared to other healthcare settings, which is another key driver for market growth. More radiosurgery procedures are conducted in hospitals than in other medical facilities, contributing to the large share of this end-user segment. Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the heavy burden of cancer, rising healthcare expenditure, and increasing geriatric population prone to develop cancer. Apart from this, the rising number of hospitals and cancer care centers in the APAC region is expected to propel the market for foot and ankle devices. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights4.1 Oncology Information Systems Market Overview4.2 Oncology Information Systems Market, by Product & Service, 2020 Vs. 2025 (USD Million)4.3 APAC: Oncology Information Systems Market Share, by Country and Application (2019)4.4 Oncology Information Systems Market Share, by End-user, 2020 Vs. 20254.5 Oncology Information Systems Market: Geographic Growth Opportunities 5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers188.8.131.52 Cost-Benefits of Ois Vis-A-Vis Rising Healthcare Expenditure184.108.40.206 Growing Adoption of Ehrs and Other Oncology Healthcare It Solutions to Improve Care Quality220.127.116.11 Increasing Incidence and Prevalence of Cancer18.104.22.168 Favorable Government Mandates and Support for Oncology Information Systems22.214.171.124 Potential Benefits of and Technological Advancements in Oncology Information Systems5.2.2 Restraints126.96.36.199 Interoperability Issues188.8.131.52 High Cost of Oncology Information Systems5.2.3 Opportunities184.108.40.206 Growing Healthcare IT Industry220.127.116.11 Integration of Emr with Treatment Planning Systems5.2.4 Challenges18.104.22.168 Integration Between Various Oncology Information Systems Within the Healthcare Industry5.3 Technology Analysis: Healthcare It Solutions5.4 Ecosystem Landscape: Healthcare It Market5.5 Regulatory Analysis5.5.1 North America22.214.171.124 US126.96.36.199 Canada5.5.2 Europe5.5.3 Asia-Pacific188.8.131.52 Japan184.108.40.206 China220.127.116.11 India5.6 COVID-19 Impact 6 Oncology Information Systems Market, by Product & Service6.1 Introduction6.2 Software6.2.1 Patient Information Systems18.104.22.168 Oncology Electronic Medical Records22.214.171.124.1 the Adoption of Oncology Electronic Health Records is Growing Significantly in Emerging Countries126.96.36.199 Laboratory Information Systems188.8.131.52.1 the Need for Accurate, Efficient, and Rapid Transfer of Lab Results Across Networks to Drive Market Growth184.108.40.206 Radiology Information Systems220.127.116.11.1 the Integration of Ris with His and Pacs Has Attracted Attention from Stakeholders18.104.22.168 Chemotherapy Information Systems22.214.171.124.1 Chemotherapy is Increasingly Being Adopted as a Primary Mode of Treatment for Various Cancer Types6.2.2 Treatment Planning Systems126.96.36.199 Radiotherapy Treatment Planning Systems188.8.131.52.1 Radiotherapy Treatment Planning Systems to Witness Increased Adoption for the Treatment of Deep-Seated Tumors184.108.40.206 Clinical Decision Support Systems220.127.116.11.1 Need to Minimize Errors and Ensure Regulatory Compliance to Drive the Adoption of Cdss18.104.22.168 Brachytherapy Treatment Planning Systems22.214.171.124.1 Better Patient Care with Pulsed-Dose Rate Brachytherapy to Drive the Demand for Brachytherapy Treatment Planning Systems6.2.3 Treatment Management Systems & Medical Image Analysis Systems126.96.36.199 Population Health Management Solutions188.8.131.52.1 Phm Solutions Aggregate and Provide a Wide Range of Cancer Data for Providers184.108.40.206 Clinical Integration Solutions220.127.116.11.1 Increasing Number of Cancer Patient Admissions in Inpatient Facilities is a Key Driver18.104.22.168 Picture Archiving and Communication Systems & Vendor-Neutral Archive Solutions22.214.171.124.1 Rising Demand for Pacs and Growing Generation of Image Data Will Ensure Sustained Demand for Solutions126.96.36.199 Advanced Visualization and Image Analysis Solutions188.8.131.52.1 Increasing Demand for Imaging Modalities in Various Indications of Oncology to Drive the Segment Growth184.108.40.206 Radiation Dose Management Solutions220.127.116.11.1 Use of These Solutions Allows for the Optimization of Radiation Dose Administration and Management6.3 Professional Services6.3.1 Implementation Services18.104.22.168 Healthcare Organizations Are Increasingly Outsourcing Implementation Services6.3.2 Post-Sales & Maintenance Services22.214.171.124 Rising Trend of Outsourcing Driving the Market for Support & Maintenance Services6.3.3 Consulting & Optimization Services126.96.36.199 Consulting Services Deliver Optimum Guidance to Healthcare Providers for Implementing Oncology Information Solutions 7 Oncology Information Systems Market, by Application7.1 Introduction7.2 Radiation Oncology7.2.1 Growing Number of Radiation-Treated Cancer Survivors Enhancing the Growth of Oncology Information Systems7.3 Medical Oncology7.3.1 Rising Prevalence of Cancer to Drive Market Growth7.4 Surgical Oncology7.4.1 Need for Structured Healthcare Information Systems to Boost Market Growth 8 Oncology Information Systems Market, by End-user8.1 Introduction8.2 Hospitals & Diagnostic Imaging Centers8.2.1 Hospitals and Diagnostic Imaging Centers Are the Largest End-users of Oncology Information Systems8.3 Ablation & Cancer Care Centers8.3.1 Initiation of Cancer Care Programs and Supporting Reimbursement Plans to Boost the Growth of this Segment8.4 Government Institutions8.4.1 Rising Government Initiatives to Drive Market Growth8.5 Research Facilities8.5.1 Growing Number of Cancer Research Studies to Drive Market Growth 9 Oncology Information Systems Market, by Region9.1 Introduction9.2 North America9.3 Europe9.4 Asia-Pacific9.5 Latin America9.6 Middle East & Africa 10 Competitive Landscape10.1 Overview10.2 Global Market Share Analysis (2019)10.3 Competitive Scenario (2017-2020)10.3.1 Key Product Launches, Product Enhancements, and Product Approvals10.3.2 Key Expansions10.3.3 Key Mergers and Acquisitions10.3.4 Key Agreements, Collaborations, and Partnerships10.4 Competitive Leadership Mapping10.5 Vendor Inclusion Criteria10.5.1 Stars10.5.2 Emerging Leaders10.5.3 Pervasive Players10.5.4 Participants10.6 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-Ups (2019)10.6.1 Progressive Companies10.6.2 Starting Blocks10.6.3 Responsive Companies10.6.4 Dynamic Companies 11 Company Profiles11.1 Mckesson Corporation11.2 Varian Medical Systems, Inc.11.3 Elekta Ab11.4 Siemens Healthineers11.5 Philips Healthcare11.6 GE Healthcare11.7 Cerner Corporation11.8 IBM11.9 Accuray Incorporated11.10 Epic Systems Corporation11.11 Allscripts Healthcare Solutions, Inc.11.12 F. Hoffmann-La Roche Ag11.13 Raysearch Laboratories Ab11.14 Curemd Healthcare11.15 Bogardus Medical Systems, Inc.11.16 Other Companies11.16.1 Optum11.16.2 Mica Information Systems, Inc.11.16.3 Advanced Data Systems11.16.4 Endosoft, LLC11.16.5 Amerisourcebergen Corporation 12 Appendix12.1 Discussion Guide12.2 Knowledge Store: Subscription Portal12.3 Available Customizations12.4 Related Reports12.5 Author Details For more information about this report visit https://www.researchandmarkets.com/r/75g41n CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Enter Now Through March 31st for a Chance to “Stalk the Fridge”!Oviedo, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- Dandy® Celery, leading grower of fresh celery, launches its 4th annual sweepstakes in celebration of National Celery Month during the month of March! Now through March 31st, participants can enter HERE for a chance to win prizes to help “Stalk the Fridge” and ‘celery-brate’ the holiday! Bonus entries can also be placed on Instagram. ‘Stalk’ worthy prizes include a $500 Visa gift card, a Vitamix Explorian E310 Series Blender and a hefty supply of fresh Dandy celery. The winner of the grand prize will be notified via email the first week of April. “Each year, we look forward to celebrating an entire month fully dedicated to celery with our fans,” said Nichole Towell, senior director of marketing and packaging procurement at Duda Farm Fresh Foods. “We are happy to be able to offer fans something fun and engaging with the possibility of winning some awesome prizes during what has certainly been an unprecedented year.” Dandy celery is naturally sweeter, crispier, and less stringy than other celery brands on store shelves. The company is committed to providing inspiration for healthy and delicious snacking ideas. To learn more, check out info.dudafresh.com/national-celery-month-2021 and enter for a chance to win. # # # About Dandy® Celery For nearly 100 years, Duda Farm Fresh Foods has been a leading grower, shipper, processor and marketer of fresh vegetables and citrus. Known for their superior celery, the company has expanded their facilities over the years to accommodate recent developments such as celery juicing and other health and wellness trends in order to provide consumers with the freshest celery possible. With primary locations in Florida, California, Arizona, Georgia and Michigan, Duda Farm Fresh Foods carries a commitment to innovation and sustainability and believes in growing a healthy future for generations to come. The company is a wholly owned subsidiary of A. Duda & Sons, Inc., a family-owned, diversified land company headquartered in Oviedo, Fla. For more information, please visit www.dudafresh.com. CONTACT: Nichole Towell Duda Farm Fresh Foods 561-804-1477 firstname.lastname@example.org
Six Dr Seuss books - including And to Think That I Saw It on Mulberry Street and If I Ran the Zoo - will stop being published because of racist and insensitive imagery, the business that preserves and protects the author's legacy says."These books portray people in ways that are hurtful and wrong," Dr Seuss Enterprises told The Associated Press in a statement that coincided with the late author and illustrator's birthday.